ChromaDex Wins International 2022 European NutraIngredients Award for Developing the Science Behind Niagen®

LOS ANGELES–(BUSINESS WIRE)—- $CDXC #NAD–ChromaDex Corp. (NASDAQ:CDXC) announced today that NutraIngredients, a leading news source for the nutrition industry, recently honored the ChromaDex External Research Program (CERPTM) with a 2022 European NutraIngredients Award in the “Nutrition Research Project” category for developing the science behind ChromaDex’s proprietary and patented Niagen® nicotinamide…